Risk factors for Chagas' disease reactivation after heart transplantation

Sílvia V Campos1, Tânia Mara V Strabelli, Vicente Amato Neto

  • 1Department of Infectious and Parasitic Diseases, University of São Paulo Medical School, São Paulo, Brazil. silviavcampos@uol.com.br

Insights

Reactivation of Chagas' disease after heart transplantation is linked to increased immunosuppression, specifically from rejection episodes and neoplasms. Early diagnosis and preemptive therapy are crucial for managing this risk.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Transplantation Immunology

Background:

  • Chagas' disease, caused by Trypanosoma cruzi, remains endemic in Latin America.
  • Heart transplantation is a vital option for end-stage Chagas' cardiomyopathy.
  • Post-transplant reactivation of Chagas' disease can lead to severe complications.

Purpose of the Study:

  • To identify risk factors for Chagas' disease reactivation after heart transplantation.
  • To understand the determinants of post-transplant Chagas' disease reactivation.

Main Methods:

  • Retrospective cohort study of heart transplant recipients with Chagas' disease (1985-2004).
  • Review of clinical, microbiologic, and histopathologic data.
  • Statistical analysis using SPSS software.

Main Results:

  • 17 out of 64 patients (26.5%) experienced Chagas' disease reactivation.
  • Independent risk factors for reactivation included multiple rejection episodes, development of neoplasms, and use of mycophenolate mofetil.
  • Age, gender, cytomegalovirus infection, and mortality did not show significant association.

Conclusions:

  • Increased immunosuppression, indicated by rejection episodes and neoplasms, elevates the risk of Chagas' disease reactivation.
  • Physicians should be vigilant for early diagnosis and consider preemptive treatment.
  • While reactivation causes significant morbidity, mortality risk is low.
Abstract

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...